ACE-inhibitors: Panacea for progressive renal disease?

被引：33

作者：

Navis, G

deZeeuw, D

deJong, PE

机构：

来源：

LANCET | 1997年 / 349卷 / 9069期

关键词：

D O I：

10.1016/S0140-6736(97)22026-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1852 / 1853

页数：2

共 12 条

[1] APPERLOO AJ, 1994, KIDNEY INT, V45, pS174
[2] Ellis A, 1942, LANCET, V1, P72
[3] GANSEVOORT RT, 1993, AM J KIDNEY DIS, V2, P202
[4] Giatras I., 1996, Journal of the American Society of Nephrology, V7, P1318
[5] GIATRAS I, IN PRESS ANN INTERN
[6] RANDOMIZED CONTROLLED TRIAL OF ENALAPRIL AND BETA-BLOCKERS IN NONDIABETIC CHRONIC-RENAL-FAILURE
HANNEDOUCHE, T
LANDAIS, P
GOLDFARB, B
ELESPER, N
FOURNIER, A
GODIN, M
DURAND, D
CHANARD, J
MIGNON, F
SUC, JM
GRUNFELD, JP
[J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6958) : 833 - 837
[7] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY
LEWIS, EJ
HUNSICKER, LG
BAIN, RP
ROHDE, RD
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) : 1456 - 1462
[8] Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
Maschio, G
Alberti, D
Janin, G
Locatelli, F
Mann, JFE
Motolese, M
Ponticelli, C
Ritz, E
Zucchelli, P
Marai, P
Marcelli, D
Tentori, F
Andriani, M
Drago, G
Meneghel, G
Oldrizzi, L
Rugiu, C
Salvadeo, A
Villa, G
Picardi, L
Borghi, M
Moriggi, M
Vendramin, G
Fusaroli, M
Esposti, ED
Fabbri, A
Koch, KM
Frey, U
Schaeffer, J
Mann, J
Schweitzer, C
Zuccala, A
Gaggi, R
Stahl, R
Blaser, C
Rivolta, E
Buccianti, G
Gastaldi, L
Baratelli, M
Ducret, F
Pointet, P
Sterzel, R
Oberdorf, E
Pedrini, L
Faranna, P
Cairo, G
Ferrari, L
Albertazzi, A
Cappelli, P
Cantu, P
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) : 939 - 945
[9] Parving HH, 1996, BRIT MED J, V313, P591
[10] Van Essen Gabe G., 1996, Journal of the American Society of Nephrology, V7, P1400

← 1 2 →